Dr. Uwe Gottschalk is a globally recognized bioprocessing expert and innovation leader with over 30 years of experience in the biopharmaceutical industry. As Chief Technology Officer and later Chief Scientific Officer at Lonza, he spearheaded major innovations in biologics development and manufacturing. He previously held senior roles at Sartorius Stedim Biotech and Bayer HealthCare, shaping global bioseparation technologies.

Renowned for his ability to translate scientific advances into scalable industrial solutions, Dr. Gottschalk now advises companies as Operating Partner at Keensight Capital and serves on multiple biotech boards. His lifetime of innovation was honored with the Bioprocessing Lifetime Achievement Award in 2021.